Health-Related Quality of Life in Gay Men With Localized Prostate Cancer
Patient-Reported Outcomes For Gay Men With Localized Prostate Cancer
RATIONALE: Gathering information about prostate cancer, treatment, and quality of life from gay men with prostate cancer may help doctors plan the best treatment.
PURPOSE: This clinical trial is collecting information about health-related quality of life from gay men with localized prostate cancer.
Aperçu de l'étude
Statut
Les conditions
Description détaillée
OBJECTIVES:
- To enroll 200 gay men with localized prostate cancer in a cross-sectional study of prostate cancer outcomes.
- To complete an R01 application using pilot data collected from these patients.
- To complete manuscripts describing the factors that influence quality of life and treatment satisfaction in these patients.
OUTLINE: Patients complete a web-based survey about their disease (biopsy Gleason score, PSA at diagnosis, and T-stage), treatment (treatment type, time since treatment, and use of healthcare services [e.g., oral medications for erectile dysfunction]), symptom distress, and psychosocial factors (ethnicity, health literacy, level of social support, communication with provider, relationship status, and communication with partner) that affect their health-related quality of life. The data will be used to provide the information necessary to tailor an existing prostate cancer survivorship intervention to address the specific needs of gay men with prostate cancer.
Type d'étude
Inscription (Réel)
Contacts et emplacements
Lieux d'étude
-
-
Ontario
-
Toronto, Ontario, Canada, M5B 2K3
- Ryerson University
-
-
-
-
Texas
-
Houston, Texas, États-Unis, 77030
- Veterans Affairs Medical Center - Houston
-
Houston, Texas, États-Unis, 77030
- Dan L. Duncan Cancer Center at Baylor College of Medicine
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
Méthode d'échantillonnage
Population étudiée
La description
DISEASE CHARACTERISTICS:
Diagnosis of localized prostate cancer
- No advanced disease
- Self-identified as gay
PATIENT CHARACTERISTICS:
- Able to complete an online questionnaire
- Able to speak and understand English
PRIOR CONCURRENT THERAPY:
- Not specified
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Délai |
|---|---|
|
Effect of disease factors and treatment factors on subjective well-being
Délai: Cross-sectional retrospective study, one timepoint
|
Cross-sectional retrospective study, one timepoint
|
|
Effect of disease factors and treatment factors on illness intrusiveness
Délai: Cross-sectional retrospective study, one timepoint
|
Cross-sectional retrospective study, one timepoint
|
|
Effect of psychosocial factors on subjective well-being
Délai: Cross-sectional retrospective study, one timepoint
|
Cross-sectional retrospective study, one timepoint
|
Collaborateurs et enquêteurs
Parrainer
Les enquêteurs
- Chercheur principal: David M. Latini, PhD, Baylor College of Medicine
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude
Achèvement primaire (Réel)
Achèvement de l'étude (Réel)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Estimation)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- CDR0000600597
- BCM-H-21892 (Autre identifiant: Baylor College of Medicine)
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .